CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1

被引:0
|
作者
Aoki, Yoshitaka [1 ]
Yanaizu, Motoaki [1 ]
Ohki, Ai [1 ]
Nishimiya, Kai [1 ]
Kino, Yoshihiro [1 ]
机构
[1] Meiji Pharmaceut Univ, Dept RNA Pathobiol & Therapeut, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan
关键词
MUSCLEBLIND PROTEINS; SKELETAL-MUSCLE; LOCALIZATION;
D O I
10.1016/j.bbrc.2024.150729
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myotonic dystrophy type 1 (DM1) is caused by the expansion of a non-coding CTG repeat in DMPK. . CUG-repeat-containing transcripts sequester the splicing regulator MBNL1 into nuclear RNA foci, causing aberrant splicing of many genes. Although the mislocalization of MBNL1 represents a causal event in DM1 pathogenesis, the effect of CUG repeat RNA on the protein level of MBNL1 remains unclear. Using a DM1 model cell line, we found that CUG repeat RNA caused a significant decrease in the protein, but not mRNA levels, of MBNL1. As CUG repeats did not decrease MBNL1 translation, we investigated protein degradation pathways. Although autophagy-related reagents induced little change, proteasome inhibitors partially recovered MBNL1 protein expression levels under conditions of CUG repeat expression and induced a slight, but significant, reversal of splicing dysregulation. MBNL1 was detected in the polyubiquitinated protein fraction, but MBNL1 polyubiquitination was not detected. Moreover, inhibition of the ubiquitin-activating enzyme E1 did not increase MBNL1 levels, suggesting that MBNL1 is a substrate of polyubiquitin-independent proteasomal degradation. These results suggest that CUG-repeat-induced proteasomal degradation partially contributes to the functional decline of MBNL1.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy
    Lee, Kuang-Yung
    Seah, Carol
    Li, Ching
    Chen, Yu-Fu
    Chen, Chwen-Yu
    Wu, Ching-, I
    Liao, Po-Cheng
    Shyu, Yu-Chiau
    Olafson, Hailey R.
    McKee, Kendra K.
    Wang, Eric T.
    Yeh, Chi-Hsiao
    Wang, Chao-Hung
    HUMAN MOLECULAR GENETICS, 2022, 31 (18) : 3144 - 3160
  • [32] Computational Investigation of RNA CUG Repeats Responsible for Myotonic Dystrophy 1
    Yildirim, Ilyas
    Chakraborty, Debayan
    Disney, Matthew D.
    Wales, David J.
    Schatz, George C.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2015, 11 (10) : 4943 - 4958
  • [33] MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1
    Tahraoui-Bories, Julie
    Merien, Antoine
    Gonzalez-Barriga, Anchel
    Laine, Jeanne
    Leteur, Celine
    Polveche, Helene
    Carteron, Alexandre
    De Lamotte, Juliette Duchesne
    Nicoleau, Camille
    Polentes, Jerome
    Jarrige, Margot
    Gomes-Pereira, Mario
    Ventre, Erwann
    Poydenot, Pauline
    Furling, Denis
    Schaeffer, Laurent
    Legay, Claire
    Martinat, Cecile
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (01)
  • [34] MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway
    Song, Kai-Yi
    Guo, Xiu-Ming
    Wang, Hui-Qi
    Zhang, Lei
    Huang, Si-Yuan
    Huo, Ying-Chao
    Zhang, Gang
    Feng, Jin-Zhou
    Zhang, Rong-Rong
    Ma, Yue
    Hu, Qing-Zhe
    Qin, Xin-Yue
    CELL DEATH & DISEASE, 2020, 11 (07)
  • [35] Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing
    Dhaenens, C. M.
    Tran, H.
    Frandemiche, M-L.
    Carpentier, C.
    Schraen-Maschke, S.
    Sistiaga, A.
    Goicoechea, M.
    Eddarkaoui, S.
    Van Brussels, E.
    Obriot, H.
    Labudeck, A.
    Gevaert, M. H.
    Fernandez-Gomez, F.
    Charlet-Berguerand, N.
    Deramecourt, V.
    Maurage, C. A.
    Buee, L.
    Lopez de Munain, A.
    Sablonniere, B.
    Caillet-Boudin, M. L.
    Sergeant, N.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (07): : 732 - 742
  • [36] MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway
    Kai-Yi Song
    Xiu-Ming Guo
    Hui-Qi Wang
    Lei Zhang
    Si-Yuan Huang
    Ying-Chao Huo
    Gang Zhang
    Jin-Zhou Feng
    Rong-Rong Zhang
    Yue Ma
    Qing-Zhe Hu
    Xin-Yue Qin
    Cell Death & Disease, 11
  • [37] Small molecules that control the fate of CUG RNA repeats, the causative agent in myotonic dystrophy type 1
    Lien Nguyen
    Zimmerman, Steven C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [38] Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2
    Carpentier, C.
    Ghanem, D.
    Fernandez-Gomez, F. J.
    Jumeau, F.
    Philippe, J. V.
    Freyermuth, F.
    Labudeck, A.
    Eddarkaoui, S.
    Dhaenens, C. M.
    Holt, I.
    Behm-Ansmant, I.
    Marmier-Gourrier, N.
    Branlant, C.
    Charlet-Berguerand, N.
    Marie, J.
    Schraen-Maschke, S.
    Buee, L.
    Sergeant, N.
    Caillet-Boudin, M. L.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (04): : 654 - 664
  • [39] Structural basis for water modulating RNA duplex formation in the CUG repeats of myotonic dystrophy type 1
    Wang, Shun-Ching
    Chen, Yi-Tsao
    Satange, Roshan
    Chu, Jhih-Wei
    Hou, Ming-Hon
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (07)
  • [40] Dynamic docking of small molecules targeting RNA CUG repeats causing myotonic dystrophy type 1
    Wang, Kye Won
    Riveros, Ivan
    DeLoye, James
    Yildirim, Ilyas
    BIOPHYSICAL JOURNAL, 2023, 122 (01) : 180 - 196